Trial Profile
A phase 2, double-blind, randomized, placebo-controlled, parallel-group, multicenter proof-of-concept study to evaluate the safety and efficacy of Rozerem taken in combination with gabapentin for treatment of subjects with chronic insomnia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jun 2013
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary) ; Gabapentin
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Takeda
- 04 Jun 2010 Additional trial identifier U1111-1114-3348 identified as reported by ClinicalTrials.gov.
- 18 Sep 2008 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 10 Aug 2006 New trial record.